PEAK6 Investments’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-730
Closed -$401K 6127
2022
Q1
$401K Sell
730
-1,650
-69% -$997K ﹤0.01% 3335
2021
Q4
$1.57M Buy
2,380
+1,050
+79% +$803K ﹤0.01% 2129
2021
Q3
$1.12M Sell
1,330
-1,200
-47% -$1.22M ﹤0.01% 2499
2021
Q2
$3.21M Buy
+2,530
New +$2.86M 0.01% 1457

Other funds holding CDLX

PEAK6 Investments's CDLX Position: Q2 2022 in Review

PEAK6 Investments sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 607 shares — an estimated $334K sold.

PEAK6 Investments first reported a position in CDLX in Q2 2021 and held it in 3 quarters. The position peaked at $874K in Q2 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • PEAK6 Investments reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • PEAK6 Investments sold 607 Cardlytics shares in Q2 2022, an estimated $334K.
  • PEAK6 Investments first reported a position in Cardlytics in Q2 2021 and held it in 3 quarters.
  • PEAK6 Investments's Cardlytics position peaked at $874K in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.